Abstract #906: Squamous Cell Carcinoma of the Pituitary Stalk, A Primary Cancer

2016 ◽  
Vol 22 ◽  
pp. 196
Author(s):  
Viviana Ortiz-Santiago ◽  
Oscar Ruiz ◽  
Milliette Alvarado Santiago ◽  
Loida Gonzalez-Rodriguez ◽  
Margarita Ramirez-Vick
Thorax ◽  
2019 ◽  
Vol 74 (5) ◽  
pp. 466-472 ◽  
Author(s):  
Matthew E Barclay ◽  
Georgios Lyratzopoulos ◽  
Fiona M Walter ◽  
Sarah Jefferies ◽  
Michael D Peake ◽  
...  

BackgroundLung cancer 5-year survival has doubled over 15 years. Although the risk of second primary cancer is recognised, quantification over time is lacking. We describe the incidence of second and higher order smoking-related primary cancers in lung cancer survivors, identifying high-incidence groups and how incidence changes over time from first diagnosis.MethodsData on smoking-related primary cancers (lung, laryngeal, head and neck, oesophageal squamous cell carcinoma and bladder) diagnosed in England between 2000 and 2014 were obtained from Public Health England National Cancer Registration and Analysis Service. We calculated absolute incidence rates and standardised incidence rate ratios, both overall and for various subgroups of second primary cancer for up to 10 years from the initial diagnosis of lung cancer, using Poisson regression.ResultsElevated incidence of smoking-related second primary cancer persists for at least 10 years from first lung cancer diagnosis with those aged 50 and 79 at first diagnosis at particularly high risk. The most frequent type of second malignancy was lung cancer although the highest standardised incidence rate ratios were for oesophageal squamous cell carcinoma (2.4) and laryngeal cancers (2.8) and consistently higher in women than in men. Over the last decade, the incidence of second primary lung cancer has doubled.ConclusionLung cancer survivors have increased the incidence of subsequent lung, laryngeal, head and neck and oesophageal squamous cell carcinoma for at least a decade from the first diagnosis. Consideration should be given to increasing routine follow-up from 5 years to 10 years for those at highest risk, alongside surveillance for other smoking-related cancers.


Head & Neck ◽  
2020 ◽  
Vol 42 (8) ◽  
pp. 1848-1858
Author(s):  
Rayan Mroueh ◽  
Aapeli Nevala ◽  
Aaro Haapaniemi ◽  
Janne Pitkäniemi ◽  
Tuula Salo ◽  
...  

2008 ◽  
Vol 33 (12) ◽  
pp. 831-833 ◽  
Author(s):  
Bayarkhuu Bold ◽  
Yongnan Piao ◽  
Yuji Murata ◽  
Mitsuhiro Kishino ◽  
Hitoshi Shibuya

Head & Neck ◽  
2015 ◽  
Vol 38 (S1) ◽  
pp. E511-E518 ◽  
Author(s):  
Masahiro Kikuchi ◽  
Shogo Shinohara ◽  
Megumu Hino ◽  
Kyo Itoh ◽  
Risa Tona ◽  
...  

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 5569-5569 ◽  
Author(s):  
T. Bhandari

5569 Background: Panendoscopy (triple endoscopy) has historically been advocated to adequately stage patients w/ head & neck squamous cancer, especially in the setting of neoadjuvant therapy. This role is controversial by in view of comparable information provided by current imaging techniques Objective: The primary objective was to analyze the results of panendoscopy in a series of patients enrolled in a neoadjuvant chemo radiation protocol. Methods: We reviewed the panendoscopy results of 69 pts w/ stage III/IV head & neck squamous cell carcinoma (H&N ca) treated w/ neoadjuvant chemo radiation at a single institution from 1996–2005. All pts had detailed laryngoscopy/microlaryngoscopy w/ strategic biopsies, esophago-duodeno-scopy (selected biopsies for Barretts) & placement of percutaneous gastrostomy (PEG) & bronchoscopy washings for cytology. Pts were initially treated w/chemo radiation protocols (H&N 53,67); subsequent protocols utilized induction chemotherapy/chemo radiation (H&N 79,86). Results: Two of 69 pts had malignant cells in bronchial cytology in absence of any lung findings (both were NED at 5 yrs). A radiologically occult primary bronchial cancer was found in an additional pt excluding pt from the protocol. Two pts were diagnosed w/ Barrett’s esophagus; another pt also had a synchronous primary cancer of the cervical esophagus. Nine of 69 pts underwent panendoscopy for cervical metastases from an apparent unknown primary ca (at initial diagnosis). The primary cancer was demonstrated in 6 pts at staging panendoscopy and in another patient at follow up panendoscopy. Conclusion: Panendoscopy is essential in staging high risk H & N ca pts prior to initiation of therapy. A detailed laryngoscopy (micro-laryngoscopy) w/ strategic biopsies is required for adequate staging of all cancers of oropharynx & larynx. Esophago-gastro-duodenoscopy had a low but definable yield, but is also necessary for PEG placement to ensure adequate nutrition during neoadjuvant therapy. Bronchoscopy has a limited role in the absence of radiologic chest findings. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document